1. Quotes

    1-10 of 876 1 2 3 4 ... 86 87 88 »
    1. Publisher: ecancer
      Cancer is a significant cause of death in children and adolescents, in spite of its relatively rare occurrence before the age of 20 years.
      - In Latest data show a global increase of 13% in childhood cancer incidence over two decades
    2. Publisher: ScienceDaily
      In this study, we looked to Mother Nature for answers and we were rewarded.
      - In Success of sensory cell regeneration raises hope for hearing restoration
    3. Publisher: ScienceDaily
      Work in other organs has shown that reprogramming cells is rarely accomplished by manipulating a single factor.
      - In Success of sensory cell regeneration raises hope for hearing restoration
    4. Publisher: ScienceDaily
      This study suggests that targeting p27, GATA3 and POU4F3 may enhance the outcome of gene therapy and other approaches that aim to restart ATOH1 expression.
      - In Success of sensory cell regeneration raises hope for hearing restoration
    5. Publisher: ScienceDaily
      Work continues to identify the other factors, including small molecules, necessary to not only promote the maturation and survival of the newly generated hair cells, but also increase their number.
      - In Success of sensory cell regeneration raises hope for hearing restoration
    6. Publisher: ecancer
      We wanted to determine if certain genotypes that are related to immune cells called NK cells— KIR/KIR-ligand genotypes—could be predictive of how patients with high-risk neuroblastoma respond to immunotherapy.
      - In Biomarker may identify neuroblastoma patients most likely to benefit from immunotherapy
    7. Publisher: ecancer
      Our data show that a certain combination of KIR/KIR-ligand genotypes may be predictive of benefit from immunotherapy
      - In Biomarker may identify neuroblastoma patients most likely to benefit from immunotherapy
    8. Publisher: ecancer
      Our data not only identify KIR/KIR-ligand genotypes associated with differences in outcome following treatment with immunotherapy but also indicate that the immune cells that are regulated by KIR/KIR-ligand interactions, namely NK cells, play a major role in mediating the anticancer effects of this immunotherapy treatment.
      - In Biomarker may identify neuroblastoma patients most likely to benefit from immunotherapy
    9. Publisher: aacr.org
      We wanted to determine if certain genotypes that are related to immune cells called NK cells—KIR/KIR-ligand genotypes—could be predictive of how patients with high-risk neuroblastoma respond to immunotherapy.
      - In Biomarker May Identify Neuroblastoma Patients Most Likely to Benefit from Immunotherapy
    10. Publisher: aacr.org
      Our data show that a certain combination of KIR/KIR-ligand genotypes may be predictive of benefit from immunotherapy
      - In Biomarker May Identify Neuroblastoma Patients Most Likely to Benefit from Immunotherapy
    1-10 of 876 1 2 3 4 ... 86 87 88 »
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Most Quoted Topics